Circulating insulin-like growth factor-1 (IGF-1) is positively associated with the risk of BC recurrence, and is more frequently dysregulated in older people, especially in those with metabolic syndrome (MetS) and obesity. This evidence concerns the gene IGF1 and obesity due to melanocortin 4 receptor deficiency.